Aarti Industries shares fell 4.13% to Rs 491.90 on Tuesday despite the specialty chemicals company reporting a 42.7% year-on-year jump in net profit to Rs 137 crore for Q4 FY26. The selloff pattern is familiar for Aarti Industries investors — the headline numbers beat on PAT, but the market is focused on everything else: cautious guidance, margin trajectory and management credibility.
The results that looked good on the surface
Net profit rose 42.7% year-on-year to Rs 137 crore. Revenue grew 13.2% to Rs 2,206 crore. EBITDA grew 30.4% to Rs 343 crore. The board recommended a dividend of Rs 1 per share. Strategically, the company signed a $150 million multi-year supply agreement with an agrochemical major extending till 2030 and announced a backward integration initiative with a global chemical company carrying capex of Rs 200-250 crore.
So why are shares falling?
Three reasons — and all three are the same reasons that have caused Aarti Industries shares to sell off on results day repeatedly over the past three years.
The first is cautious management guidance. Management described itself as “cautiously optimistic” for FY27 — language that signals uncertainty rather than confidence. Investors in a specialty chemicals stock trading at premium multiples expect visibility and conviction from management, not hedged language. The company cited persistent risks from the West Asia conflict on supply chains, logistics and input costs as headwinds that remain unresolved.
The second is margin quality. EBITDA margin for Q4 came in at approximately 15.5% — an improvement but still below the 18%+ levels the company was delivering two years ago. The specialty chemicals sector has been going through a valuation reset where even modest guidance cuts result in outsized stock reactions as the market adjusts from optimistic to realistic assumptions for FY27.
The third — and most damaging — is management credibility on guidance. Equirus Securities has previously noted that Aarti Industries has a history of setting lofty guidance only to repeatedly fall short since FY19, describing the pattern as “all too familiar.” When a company with that track record describes its outlook as “cautiously optimistic” amid global uncertainty, the market discounts the future earnings projection and prices in a higher margin of safety — which means selling down to a lower price.
The earnings conference call scheduled for 12:00 PM IST today will be the real test. If management provides specific, credible volume growth and margin guidance for FY27 with clear milestones, the stock could recover. If the concall mirrors the cautious tone of the results commentary, further selling pressure cannot be ruled out.
Key triggers that could reverse the decline include a quarterly result that beats reduced analyst expectations, FII buying resumption as global macro conditions improve, and management commentary providing credible FY27 guidance.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Please consult a qualified financial advisor before making investment decisions.